Multiple Sclerosis patients meet in Dubai
Links shared publicly online about this topic.
- 262total visits
Multiple Sclerosis patients meet in Dubai
View full resource at khaleejtimes.com
Tags: Multiple Sclerosis, News
Most Recently Shared on May 27, 2011 at 9:53 pm By:
Multiple Sclerosis patients meet in Dubai: DUBAI — More than 30 patients suffering from Multiple Sclerosis (MS) ... http://bit.ly/kpEg7q
Medical News: ECTRIMS: Botox Cuts MS-Related Arm Tremors - in Meeting Coverage, ECTRIMS from MedPage Today
medpagetoday.com — “AMSTERDAM -- Injections of botulinum toxin A (Botox) were a significant help to multiple sclerosis patients whose disease causes arm tremors, according to a small study reported here.” View full resource at medpagetoday.com
Most Recently Shared on October 20, 2011 at 10:36 pm By:
Botox cuts MS-related arm tremors #ECTRIMS2011: http://t.co/Qard4mbq
Gilenya and Me: A surreal encounter between epatient and pharmaceutical exec
gilenya.blogspot.com — “My story of being a hypochondriac, an MS patient, and a guinea pig.” View full resource at gilenya.blogspot.com
Most Recently Shared on September 7, 2011 at 8:06 pm By:
Chris Carswell Medical Journal
When pharma meets the epatient.. From @fingohead. Her blog documents an entire clinical trial for MS http://t.co/akJxp7Y
Medical News: CMSC: Fatigue Often First Symptom of MS - in Meeting Coverage, CMSC from MedPage Today
medpagetoday.com — “MONTREAL -- Months or even years before demyelinating events are recognized, patients later diagnosed with multiple sclerosis often turn up in their doctors' offices complaining of fatigue, a research” View full resource at medpagetoday.com
Most Recently Shared on August 18, 2011 at 6:45 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
CMSC: Fatigue Often First Symptom of MS - in Meeting Coverage, CMSC from MedPage Today - http://t.co/b1ua8nr from @medpagetoday
Medical News: CMSC: Novel MS Drug May Boost Glatiramer Efficacy - in Meeting Coverage, CMSC from MedPage Today
medpagetoday.com — “MONTREAL -- Adding the investigational, oral drug teriflunomide to glatiramer acetate (GA, Copaxone) in patients with relapsing multiple sclerosis substantially decreased the MRI lesion burden, althou” View full resource at medpagetoday.com
Most Recently Shared on August 18, 2011 at 6:43 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
CMSC: Novel MS Drug May Boost Glatiramer Efficacy - in Meeting Coverage, CMSC from MedPage Today - http://t.co/Df0q7Bu from @medpagetoday
Medical News: AAN: In MS, Memory Melts in Warm Weather - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- When it's warm outside, memory, processing speed, and other aspects of cognition slow down for patients with multiple sclerosis, researchers found.” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:56 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
AAN: In MS, Memory Melts in Warm Weather - in Meeting Coverage, AAN from MedPage Today - http://t.co/DCzYiQa from @medpagetoday
Medical News: AAN: At-Home Exercise Builds Muscle in MS Patients - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- Muscle strength and lung function were significantly enhanced in multiple sclerosis patients who participated in a remotely supervised at-home exercise program, a researcher said here.” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:51 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
AAN: At-Home Exercise Builds Muscle in MS Patients - in Meeting Coverage, AAN from MedPage Today - http://t.co/XfTUY5C from @medpagetoday
Medical News: AAN: Studies Nix Natalizumab Holidays - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- Relapses and/or disease progression are common among multiple sclerosis patients taking natalizumab (Tysabri) who stop the drug, casting doubt on drug holidays as a strategy for minimizi” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:49 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
Medical News: AAN: Studies Nix Natalizumab Holidays - in Meeting Coverage, AAN from MedPage Today - http://t.co/C6cWGuV from @medpagetoday
Medical News: AAN: Aerobic Exercise When Healthy Helps Save Brain - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- Multiple sclerosis patients who did aerobic exercise before the onset of their disease tended to experience less brain atrophy later, a researcher said here.” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:46 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
AAN: Aerobic Exercise When Healthy Helps Save Brain - in Meeting Coverage, AAN from MedPage Today - http://t.co/8PgMWyp from @medpagetoday
Medical News: AAN: Testing Methods at Root of CCSVI Debate - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “In this exclusive InFocus video report, a leading multiple sclerosis researcher explains one reason why some labs see cerebrospinal venous obstructions in most MS patients studied while other groups c” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:44 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
AAN: Testing Methods at Root of CCSVI Debate - in Meeting Coverage, AAN from MedPage Today - http://t.co/xpLbAMz from @medpagetoday
Medical News: AAN: Amphetamine May Cut Memory Loss in MS Patients - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- Multiple sclerosis patients with memory impairment who got l-amphetamine had nearly a 50% improvement on two memory tests, according to research reported here.” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:41 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
AAN: Amphetamine May Cut Memory Loss in MS Patients - in Meeting Coverage, AAN from MedPage Today - http://t.co/fRErAyg from @medpagetoday
Medical News: AAN: Natalizumab Risk Too Much for Most MS Patients - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- Half of multiple sclerosis patients won't accept a mortality risk greater than one in 10,000 for a treatment proven to be highly effective for most patients, researchers said here -- there” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:39 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
AAN: Natalizumab Risk Too Much for Most MS Patients - in Meeting Coverage, AAN from MedPage Today - http://t.co/KfsFVlk from @medpagetoday
Medical News: AAN: Another Oral MS Drug Shines in Trial - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- An oral investigational drug related to a common rheumatoid arthritis treatment appeared safe and effective for relapsing-remitting multiple sclerosis patients in a phase III trial, resear” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:38 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
AAN: Another Oral MS Drug Shines in Trial - in Meeting Coverage, AAN from MedPage Today - http://t.co/kjbVPcL from @medpagetoday
Study Examines High Drug Costs vs. Benefits for M.S. Patients - NYTimes.com
prescriptions.blogs.nytimes.com — “A new study finds the costs of bio-tech drugs for treating multiple sclerosis about 10 times more than what would be considered cost-effective.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on July 20, 2011 at 8:46 pm By:
Chris Morrison Health Communicator
USA meet QALYs, QALYs meet USA RT @NYTPrescription Study Examines High Drug Costs vs. Benefits for M.S. Patients http://t.co/2urcoIl
Glycominds Announces Results for the Second Clinical Trial of Blood Test | IVD Technology
ivdtechnology.com — “Glycominds Ltd. (Modi’in, Israel) announced that the positive results of the gMSPro/CDMS (gMS-Classifier2) second clinical trial for predicting early conversion to clinically definite multiple sclerosis (CDMS) were presented at the Consortium for Multiple Sclerosis (CMSC) 2011 meeting. gMS-Classifier2 is based on the level of serum antibodies against the glucose molecule P63 and patient’s age.” View full resource at ivdtechnology.com
Most Recently Shared on June 6, 2011 at 7:04 pm By:
IVD Technology Health Magazine
Glycominds Announces Results for the Second Clinical Trial of Blood Test http://tinyurl.com/3scv6hd
Medical News: CMSC: Novel MS Drug May Boost Glatiramer Efficacy - in Meeting Coverage, CMSC from MedPage Today
medpagetoday.com — “MONTREAL -- Adding the investigational, oral drug teriflunomide to glatiramer acetate (GA, Copaxone) in patients with relapsing multiple sclerosis substantially decreased the MRI lesion burden, althou” View full resource at medpagetoday.com
Most Recently Shared on June 6, 2011 at 6:57 pm By:
CMSC: Novel MS Drug May Boost Glatiramer Efficacy (CME/CE): MONTREAL (MedPage Today… http://goo.gl/fb/PYJLE
Advertisement
